- Home
- IVDA vs NXL Comparison
IVDA vs NXL Comparison
Compare IVDA & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- NXL
- Stock Information
- Founded
- IVDA 2003
- NXL 2010
- Country
- IVDA United States
- NXL United States
- Employees
- IVDA N/A
- NXL N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- NXL Medical Specialities
- Sector
- IVDA Technology
- NXL Health Care
- Exchange
- IVDA Nasdaq
- NXL Nasdaq
- Market Cap
- IVDA 9.3M
- NXL 10.0M
- IPO Year
- IVDA N/A
- NXL 2022
- Fundamental
- Price
- IVDA $2.78
- NXL $2.87
- Analyst Decision
- IVDA
- NXL Hold
- Analyst Count
- IVDA 0
- NXL 1
- Target Price
- IVDA N/A
- NXL N/A
- AVG Volume (30 Days)
- IVDA 72.7K
- NXL 377.2K
- Earning Date
- IVDA 03-04-2025
- NXL 03-26-2025
- Dividend Yield
- IVDA N/A
- NXL N/A
- EPS Growth
- IVDA N/A
- NXL N/A
- EPS
- IVDA N/A
- NXL N/A
- Revenue
- IVDA $5,305,155.00
- NXL $162,078.00
- Revenue This Year
- IVDA $23.76
- NXL $56.86
- Revenue Next Year
- IVDA $229.89
- NXL $167.44
- P/E Ratio
- IVDA N/A
- NXL N/A
- Revenue Growth
- IVDA N/A
- NXL 26.00
- 52 Week Low
- IVDA $1.27
- NXL $0.30
- 52 Week High
- IVDA $8.64
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- IVDA 38.78
- NXL 42.81
- Support Level
- IVDA $2.69
- NXL $2.80
- Resistance Level
- IVDA $3.30
- NXL $3.54
- Average True Range (ATR)
- IVDA 0.39
- NXL 0.38
- MACD
- IVDA -0.06
- NXL -0.02
- Stochastic Oscillator
- IVDA 6.75
- NXL 14.53
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.